BD announces 20 new jobs for Drogheda in an effort to expand production.
Global medtech player Becton Dickinson and Company (BD) has revealed it will create 20 new jobs in Drogheda in a €36m investment to expand production of its syringe products.
BD produces PosiFlush syringes and safety components for insulin injection at its Drogheda facility.
‘This project builds on Ireland’s expertise in medical devices’
– MARY MITCHELL O’CONNOR, TD
The investment, supported by the Department of Jobs and IDA Ireland, will facilitate the installation of two new production lines at the Drogheda plant.
The first new manufacturing line has just started production, with work also commencing on the second line.
“It will also allow us to expand the production of BD PosiFlush syringes, which are used in hospitals and medical centres throughout the world,” said Liam Dillon, BD Medical Plant Manager.
“Our team here in Drogheda will continue to manufacture high quality products that contribute to the health and well-being of patients worldwide,” he said.
IDA Ireland CEO Martin Shanahan said the investment demonstrates BD’s long-term commitment to Ireland and its 50-year history in Drogheda.
The investment comes on the heels of the news yesterday (28 September) that US company Yapstone is creating 50 new jobs in Drogheda.
“This project builds on Ireland’s expertise in medical devices and I am very pleased to see the benefits for a regional location, which follows our recently launched Action Plan for Jobs for this region,” said Jobs Minister Mary Mitchell O’Connor, TD.
Looking for jobs in tech or science? Check out our Employer Profiles for information on companies hiring right now.